nivolumab

drug

Learn about this topic in these articles:

In cancer: Immunotherapy
Anti-PD-1 therapies, such as nivolumab and pembrolizumab, have proven beneficial in patients with melanoma and certain other cancer types.
Read More
In cancer: Milestones in cancer science
Cancer immunotherapies—such as ipilimumab, nivolumab, and pembrolizumab—were also developed. These therapies, though they were associated with potentially dangerous side effects, were especially effective in mobilizing immune cells to fight tumours. American immunologist James P. Allison and Japanese immunologist Tasuku Honjo were awarded the 2018 Nobel Prize in
Read More